Education
About Us
Working with TipRanks
Follow Us
TuHURA Biosciences (HURA)
NASDAQ:HURA
Total Valuation
TuHURA Biosciences has a market cap or net worth of $171.23M. The enterprise value is ―.
Market Cap$171.23M
Enterprise Value―
Share Statistics
TuHURA Biosciences has 43,680,397 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding43,680,397
Owned by Insiders17.18%
Owned by Institutions0.72%
Financial Efficiency
TuHURA Biosciences’s return on equity (ROE) is 18.81 and return on invested capital (ROIC) is -3785.74%.
Return on Equity (ROE)18.81
Return on Assets (ROA)-6.72
Return on Invested Capital (ROIC)-3785.74%
Return on Capital Employed (ROCE)-38.89
Revenue Per Employee0.00
Profits Per Employee-1.54M
Employee Count19
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of TuHURA Biosciences is -452.28. TuHURA Biosciences’s PEG ratio is ―.
PE Ratio-452.28
PS Ratio0.00
PB Ratio87.53
Price to Fair Value-8.51K
Price to FCF-18.99
Price to Operating Cash Flow-18.92
PEG Ratio―
Income Statement
In the last 12 months, TuHURA Biosciences had revenue of 0.00 and earned -29.32M in profits. Earnings per share was -0.12.
Revenue0.00
Gross Profit0.00
Operating Income-29.76M
Pretax Income-29.32M
Net Income-29.32M
EBITDA-29.12M
Earnings Per Share (EPS)-0.12
Cash Flow
In the last 12 months, operating cash flow was -7.84M and capital expenditures -20.00K, giving a free cash flow of -7.86M billion.
Operating Cash Flow-7.84M
Free Cash Flow-7.86M
Free Cash Flow per Share-0.18
Dividends & Yields
TuHURA Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.43
52-Week Price Change-35.95%
50-Day Moving Average3.57
200-Day Moving Average4.87
Relative Strength Index (RSI)51.78
Average Volume (3m)151.41K
Important Dates
TuHURA Biosciences upcoming earnings date is Sep 30, 2025, TBA Not Confirmed.
Last Earnings DateMay 14, 2025
Next Earnings DateSep 30, 2025
Ex-Dividend Date―
Financial Position
TuHURA Biosciences as a current ratio of 1.16, with Debt / Equity ratio of 0.00%
Current Ratio1.16
Quick Ratio1.16
Debt to Market Cap<0.01
Net Debt to EBITDA0.05
Interest Coverage Ratio-1.59K
Taxes
In the past 12 months, TuHURA Biosciences has paid -1.00 in taxes.
Income Tax-1.00
Effective Tax Rate<0.01
Enterprise Valuation
TuHURA Biosciences EV to EBITDA ratio is -455.28, with an EV/FCF ratio of -1.10K.
EV to Sales0.00
EV to EBITDA-455.28
EV to Free Cash Flow-1.10K
EV to Operating Cash Flow-1.11K
Balance Sheet
TuHURA Biosciences has $3.02M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$3.02M billion.
Cash & Marketable Securities$3.02M
Total Debt$0.00
Net Cash-$3.02M
Net Cash Per Share-$0.07
Tangible Book Value Per Share-$0.02
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for TuHURA Biosciences is $13.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$13.50
Price Target Upside244.39% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast77.12%